New pill aims to tame severe skin Flare-Ups
Disease control
Not yet recruiting
This study is testing a new oral medication called RAP-103 to see if it can reduce the severity of psoriasis and improve patients' quality of life. It will involve about 90 adults with moderate-to-severe plaque psoriasis, who will take either the drug at one of two doses or a pla…
Phase: PHASE2 • Sponsor: Clarent Biopharma, Inc. • Aim: Disease control
Last updated Mar 09, 2026 14:26 UTC